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Abstract
Background: Snoring is frequently associated with obstructive sleep apnea (OSA). Previous studies have shown
that bone mineral density was significantly lower in patients with OSA than in controls; however, these studies did
not focus on fractures. Fragility fractures can lead to long-term disabilities and a decrease in quality of life. The present
study aimed to investigate the association between snoring and fragility fractures.
Methods: This study included 2969 men and 3220 women aged 40 years and older from the Ansung and
Ansan cohort studies in Korea. During a 10-year follow-up period, 129 and 273 fracture cases were reported
in men and women, respectively.
Results: Severe snoring (6–7 nights per week or sleep disturbance by snoring in the next room) was a
statistically significant risk factor for fracture (p = 0.006, hazard ratio 1.68, 95% confidence interval 1.16–2.43)
after adjusting for covariates related to fragility fracture in women. However, both snoring and severe snoring
groups did not show significant associations with the fracture risk in men.
Conclusions: Thus, information on the frequency of snoring in women may improve the accuracy of fragility fracture
risk prediction, which can help in deciding whether intervention or treatment is necessary.
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Background
Fragility fractures are a major and increasingly common
cause of morbidity, and they pose a considerable burden
on healthcare systems [1]. Moreover, most osteoporosis-
related fractures can lead to significant long-term dis-
abilities and a decrease in the quality of life [2, 3].
Screening for low bone mineral density (BMD) using
dual-energy X-ray absorptiometry (DXA) is an accepted
strategy to identify people with an elevated risk of
fragility fracture. However, mass screening with DXA in
the general population, without pre-screening for high-
risk individuals, is generally not recommended [4].
Moreover, people who have not experienced fractures
may not recognize the necessity of having their BMD
measured; therefore, people with osteoporosis may not
realize that their BMD is low before fragility fractures
actually occur. Thus, it is important to identify risk fac-
tors for fragility fractures that can be easily assessed
without special examination.
Obstructive sleep apnea (OSA) syndrome is a common
disorder characterized by recurring episodes of apnea or
hypopnea due to total or partial pharyngeal collapse dur-
ing sleep [5]. Previous studies have reported on the risk
of osteoporosis in patients with OSA. A previous retro-
spective study of 66 chronic obstructive pulmonary dis-
ease (COPD) patients found that lumbar spine BMD
was significantly lower in COPD patients with OSA than
in COPD patients without OSA [6]. Additionally, a 6-
year retrospective cohort study of 1377 OSA patients
and 20,655 matched controls found that the risk of
osteoporosis was 2.52-fold higher in the OSA patients
than in the matched controls [7]. Moreover, a 10-year
retrospective cohort study of 846 OSA patients and a
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control group of 89,380 people with no sleep disorders
found that OSA patients had an adjusted hazard ratio of
2.98 for osteoporosis when compared with the control
group [8]. Furthermore, a cross-sectional study of 26
male OSA patients and 21 male participants without
OSA showed that the spine and femoral neck BMDs
were significantly lower in the OSA patients than in the
participants without OSA [9].
Snoring is frequently associated with OSA, and pa-
tients who initially have only primary snoring may be at
risk for the future development of OSA with increasing
age or weight gain [10]. However, the above-mentioned
previous studies focused on BMD and not fragility frac-
tures. Moreover, studies on the association between
snoring and fragility fracture risk are rare. Therefore, the
objective of the present study was to investigate the
association between snoring and fragility fractures in
elderly people using data obtained in a cohort study per-
formed in Korea.
Methods
Study population
Two communities were selected for the Korean Health
and Genome Study (KHGS) in 2001; the Ansung and
Ansan cohorts represented rural and urban communi-
ties, respectively. This is an ongoing prospective study
involving a biennial examination. Detailed information
on the study design and procedures has been published
previously [11]. At each visit, informed written consent
was obtained from all participants. Initial data were ob-
tained from the 10,030 subjects who participated in the
Ansung and Ansan cohort studies. The fifth and sixth
follow-up examinations (2009–12) collected data related
to fractures. Among the 10,030 subjects, 2982 did not
participate in the fifth and sixth follow-up examinations
and were thus excluded. Among the remaining 7048
subjects, 859 subject had missing data. These subjects
were excluded from this study. Therefore, 2969 men and
3220 women were finally included in this study (Fig. 1).
The institutional review board of the Yonsei University
Health System approved the protocol of this study
(No. 4-2016-0572).
Selection of fracture events
Fracture events were recorded using a standardized self-
administered questionnaire. In this study, we only in-
cluded fracture events that occurred when the participants
fell while walking or while performing activities of daily
living. Fractures clearly caused by high-trauma events,
such as motor vehicle accidents, violence, and falls from
more than the standing height of the individual, were ex-
cluded [12]. In addition, we considered fracture events
from all sites.
Clinical risk factors
Information on the presence of snoring was obtained
using a questionnaire administered face to face. One of
the questions asked was “Have you ever been told that
you snored? If so, how many nights per week? The re-
sponse options were “rarely,” “1–3 times a week,” “4–5
times a week,” and “6–7 times a week.” Another ques-
tion asked was “Have you ever been told that your
snoring disturbed a person’s sleep in next room?” The
incidences of fractures in women were 7.4% (n = 103)
among those who did not snore, 8.4% (n = 108) among
those who rarely snored, 9.5% (n = 15) among those who
snored 1–3 times a week, 8.6% (n = 8) among those who
snored 4–5 times a week, and 13.7% (n = 39) among
those who snored 6–7 times a week. Based on the statis-
tical analysis for optimal criterion of snoring frequency,
snoring frequency was classified into the following 3
groups: non-snoring, snoring (1–5 nights per week), and
severe snoring (6–7 nights per week or sleep disturbance
by snoring in the next room). In this study, the covari-
ates for fracture included age, weight, height, body mass
index, waist circumference, hip circumference, regular
exercise, alcohol consumption, lifetime smoker, history of
previous fracture, family history of osteoporosis or frac-
ture, degenerative arthritis, rheumatoid arthritis, hyper-
tension, diabetes mellitus, medications for osteoporosis,
years since menopause, estrogen therapy, and BMD. Regu-
lar exercise was defined as engaging in any of a variety of
activities for the purpose of exercise at least once per
week. The smoking and alcohol consumption variables
were smoking status (never, former, or current) and
alcohol consumption status (never, former, or current),
respectively. The number of years since menopause was
defined as “0” for premenopausal subjects and was the
actual value for postmenopausal subjects.
Quantitative ultrasound (qUS) measurements of
BMD at the radius and tibia were performed using
the Omnisense 7000 device (Sunlight Medical, Ltd.,
Rehovot, Israel) with a handheld probe specifically de-
signed for the measurement of the axial speed of
sound (SoS, m/s) along the surface of bone [12]. In
addition, T and Z scores were calculated in both the
radius and tibia.
Statistical analysis
The characteristics of the study participants are reported
as mean ± standard deviation (SD) for continuous vari-
ables and as number (%) for categorical variables. In
order to evaluate the association between each of these
variables and the fragility fracture risk, analysis of
variance (ANOVA) was performed for each continuous
variable and the chi-square test was performed for each
categorical variable.
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Cox regression was performed to investigate whether
snoring was associated with an increase in the risk of
fragility fractures. Among the Cox regression analysis re-
sults, hazard ratios and 95% confidence intervals were
reported. The survival time was defined as the time
interval between the first examinations (2001) and the
first fragility fracture since the first examinations. Non-
fracture cases were censored at the time of the sixth
follow-up examinations (2011). First, crude univariate
Cox regression was performed without controlling for
any covariate. Second, Cox regression analysis was per-
formed after controlling for age, weight, height, waist
circumference, hip circumference, regular exercise, al-
cohol consumption, lifetime smoker, history of previous
fracture, family history of osteoporosis or fracture, de-
generative arthritis, rheumatoid arthritis, hypertension,
diabetes mellitus, years since menopause, estrogen
therapy, and qUS measurements at the radius and tibia.
Third, a Cox regression model with backward stepwise
elimination was used to restrict adjustment for con-
founding factors with a threshold of p = 0.1. The Cox
regression model proportionality of hazard assumption
was verified using the log-minus-log method (LML)
and time-dependent coefficients.
Finally, Kaplan-Meier analysis was performed in the
non-snoring, snoring, and severe snoring groups, and
the log-rank test was performed to check for statisti-
cally significant differences among these 3 groups. All
statistical analyses were two-sided and were per-
formed using SPSS 23.0 (IBM Corp., Armonk, NY). A
p-value <0.05 was considered statistically significant.
Results
Clinical characteristics of fractures
The mean (SD) survival time of the study population
was 9.5 (1.3) years for women. During the follow-up
period, 273 women (8.5% of all women) experienced
fractures. Among these 273 fracture cases, 52 (19.0% of
all fracture cases) involved the hip, 14 (5.1%) vertebrae,
33 (12.1%) wrist, 3 (1.1%) coccyx, 16 (5.9%) humerus, 17
(6.2%) forearm, 25 (9.2%) rib, 80 (29.3%) lower limb, 1
(0.4%) clavicle, and 32 (11.7%) other locations. The mean
(SD) survival time of the fracture cases was 6.6 (2.4)
years. The mean (SD) survival time of the study popula-
tion was 9.6 (1.1) years for men. During the follow-up
period, 129 men (4.3% of all men) experienced fractures
(Additional file 1: Table S1).
The results of ANOVA and the chi-square test sug-
gested that age, weight, height, body mass index, waist
circumference, hip circumference, degenerative arthritis,
rheumatoid arthritis, hypertension, diabetes mellitus,
years since menopause, SoS at the radius, T and Z scores
of the radius, SoS at the tibia, and T and Z scores of the
tibia were significantly different between the non-snoring,
snoring, and severe snoring groups in women (Table 1).
Hazard ratios for fracture
When the non-snoring group was used as the reference
group, the snoring and severe snoring groups in women
had hazard ratios of 1.14 and 1.97, respectively, in the
crude Cox regression model (Table 2). After adjusting
for all covariates, the fracture risk was 1.68-fold higher
in the severe snoring group than in the non-snoring
Korean Health and Genome Study
Subjects with missing data (N = 859)
Study Population
(N = 6,189)
1st 2001-2002 (N = 10,030)
2nd 2003-2004 (N = 8,603)
3rd 2005-2006 (N = 7,515)
4th 2007-2008 (N = 6,688)
5th 2009-2010 (N = 6,665)
6th 2011-2012 (N = 6,238)
5th or 6th 2009-2012 (N = 7,048)
Men
(N = 2,969)
Women
(N = 3,220)
Fig. 1 Flow chart of participants for the Ansung and Ansan cohort studies with subject exclusion
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group (model 2). Moreover, the Cox regression model
(model 3) with backward stepwise elimination showed
that the fracture risk was 1.68-fold higher in the severe
snoring group than in the non-snoring group. However,
the snoring group did not show a significant association
with the fracture risk in all the models. In both models 2
and 3, severe snoring, height, waist circumference, hip
circumference, family history of osteoporosis or fracture,
rheumatoid arthritis, and medications for osteoporosis
were selected as risk factors for fractures in women.
However, both the snoring and severe snoring groups
did not show significant associations with the fracture
risk in men (Additional file 1: Table S2).
Kaplan-Meier survival analysis and log-rank test
We performed Kaplan-Meier analyses and log-rank tests
to evaluate the association between snoring and fracture
risk in women (Fig. 2). The log-rank test results indicated
Table 1 Demographic and clinical characteristics of the female participants in the snoring groups (n = 3220)
Non-snoring
(n = 1398)
Snoring
(1–5 nights/week)
(n = 1493)
Severe snoring
(6–7 nights/week)
(n = 329)
p-value
Survival time (years) 9.6 ± 1.1 9.5 ± 1.4 9.3 ± 1.6 0.003*
Age (years) 51.3 ± 8.9 52.6 ± 8.6 55.7 ± 8.2 <0.001*
Weight (kg) 57.1 ± 7.8 59.8 ± 8.2 62.5 ± 8.6 <0.001*
Height (cm) 153.9 ± 5.6 154.1 ± 5.5 153.5 ± 5.5 <0.001*
Body mass index (kg/m2) 24.1 ± 3.0 25.2 ± 3.1 26.5 ± 3.2 <0.001*
Waist circumference (cm) 79.8 ± 9.2 82.3 ± 9.5 86.6 ± 9.2 <0.001*
Hip circumference (cm) 92.4 ± 5.7 93.9 ± 5.8 96.2 ± 6.2 <0.001*
Regular exercise, n (%) 325 (23.3) 366 (24.5) 69 (21.0) 0.359
Alcohol consumption, n (%) 0.314
Never 1012 (72.4) 1052 (70.5) 221 (67.2)
Past 32 (2.3) 40 (2.7) 12 (3.7)
Current 354 (25.3) 401 (26.9) 96 (29.2)
Lifetime smoker, n (%) 0.814
Never 1342 (96.0) 1438 (96.3) 312 (94.8)
Past 29 (2.1) 29 (1.9) 9 (2.7)
Current 27 (1.9) 26 (1.7) 8 (2.4)
History of previous fracture, n (%) 31 (2.2) 42 (2.8) 15 (4.6) 0.062
Family history of osteoporosis or fracture, n (%) 78 (5.6) 79 (5.3) 18 (5.5) 0.943
Degenerative arthritis, n (%) 187 (13.4) 279 (18.7) 94 (28.6) <0.001*
Rheumatoid arthritis, n (%) 98 (7.0) 118 (7.9) 37 (11.3) 0.037*
Hypertension, n (%) 172 (12.3) 289 (19.4) 89 (27.1) <0.001*
Diabetes mellitus, n (%) 60 (4.3) 86 (5.8) 35 (10.6) <0.001*
Medications for osteoporosis, n (%) 62 (4.4) 87 (5.8) 17 (5.2) 0.239
Years since menopause (years) 6.5 ± 8.5 7.2 ± 8.5 9.7 ± 8.8 <0.001*
Current estrogen therapy, n (%) 55 (3.9) 45 (3.0) 15 (4.6) 0.245
Speed of sound of radius (m/s) 4212.2 ± 185.5 4187.6 ± 186.1 4136.6 ± 187.4 <0.001*
T-score of radius 0.3 ± 1.6 0.1 ± 1.6 −0.3 ± 1.6 <0.001*
Z-score of radius 1.1 ± 1.4 0.9 ± 1.4 0.8 ± 1.4 <0.001*
Speed of sound of tibia (m/s) 3867.6 ± 164.3 3854.3 ± 161.9 3822.2 ± 171.3 <0.001*
T-score of tibia −0.8 ± 1.5 −0.9 ± 1.5 −1.2 ± 1.6 <0.001*
Z-score of tibia −0.1 ± 1.3 −0.1 ± 1.3 −0.2 ± 1.5 <0.001*
Fracture, n (%) 103 (7.4) 124 (8.3) 46 (14.0) 0.001*
Data are presented as mean ± standard deviation or number of participants (%)
The p-values of continuous and binary variables were calculated using analysis of variance (ANOVA) and the chi-square test, respectively
*p < 0.05
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that the fracture risk was significantly higher in the severe
snoring group than in the non-snoring group (p < 0.001).
Discussion
In this study, female participants with severe snoring
had a statistically significant increase in the fracture risk,
even after adjusting for covariates. To the best of our
knowledge, the present study is the first to investigate
the association between snoring and fragility fractures
using data from a 10-year cohort study. Information
about snoring can easily be obtained with history taking,
and it does not require medical examinations, such as
DXA. Thus, we expect that collecting information about
snoring may be an inexpensive and simple approach to
help increase the accuracy of the prediction of fragility
fracture events. Furthermore, if future studies identify
Table 2 Crude and adjusted hazard ratios with 95% confidence intervals for fractures among the female participants in Cox
regression analyses
Fracture Model 1 Model 2 Model 3
No
(n = 2947)
Yes
(n = 273)
p-value HR (95% CI) p-value HR (95% CI) p-value HR (95% CI)
Survival time (years) 9.8 ± 0.6 6.6 ± 2.4
Snoring, n (%)
Non-snoring 1295 (43.9) 103 (37.7) Reference Reference Reference
Snoring 1369 (46.5) 124 (45.4) 0.320 1.142 (0.879–1.483) 0.495 1.097 (0.841–1.432) 0.506 1.094 (0.840–1.424)
Severe snoring 283 (9.6) 46 (16.9) <0.001* 1.969 (1.391–2.787) 0.006* 1.682 (1.164–2.430) 0.005* 1.680 (1.168–2.416)
Age (years) 52.2 ± 8.8 54.0 ± 8.5 0.178 1.019 (0.991–1.048) 0.007* 1.023 (1.006–1.039)
Weight (kg) 58.9 ± 8.2 59.1 ± 8.3 0.956 0.999 (0.964–1.035)
Height (cm) 154.0 ± 5.5 153.1 ± 5.5 0.014* 0.966 (0.939–0.993) 0.004* 0.965 (0.941–0.988)
Body mass index (kg/m2) 24.8 ± 3.2 25.2 ± 3.2
Waist circumference (cm) 81.6 ± 9.6 82.1 ± 9.5 0.039* 0.978 (0.957–0.999) 0.006* 0.977 (0.960–0.993)
Hip circumference (cm) 93.4 ± 5.9 94.2 ± 5.7 0.014* 1.047 (1.009–1.086) <0.001* 1.048 (1.022–1.076)
Regular exercise, n (%) 693 (23.5) 67 (24.5) 0.776 1.043 (0.780–1.394)
Alcohol consumption, n (%)
Never 2088 (70.9) 197 (72.2) Reference
Former 74 (2.5) 10 (3.7) 0.375 1.336 (0.704–2.536)
Current 785 (26.6) 66 (24.2) 0.615 0.929 (0.697–1.238)
Lifetime smoker, n (%)
Never 2832 (96.1) 260 (95.2) Reference
Former 61 (2.1) 6 (2.2) 0.995 0.998 (0.441–2.256)
Current 54 (1.8) 7 (2.6) 0.423 1.365 (0.638–2.921)
History of previous fracture, n (%) 80 (2.7) 8 (2.9) 0.803 0.913 (0.448–1.862)
Family history of osteoporosis
or fracture, n (%)
154 (5.2) 21 (7.7) 0.029* 1.658 (1.052–2.612) 0.028* 1.658 (1.055–2.605)
Degenerative arthritis, n (%) 504 (17.1) 56 (20.5) 0.764 0.953 (0.694–1.308)
Rheumatoid arthritis, n (%) 219 (7.4) 34 (12.5) 0.020* 1.563 (1.073–2.278) 0.019* 1.552 (1.076–2.238)
Hypertension, n (%) 499 (16.9) 51 (18.7) 0.847 0.968 (0.698–1.342)
Diabetes mellitus, n (%) 165 (5.6) 16 (5.9) 0.860 0.955 (0.569–1.601)
Medications for osteoporosis, n (%) 141 (4.8) 25 (9.2) 0.004* 1.877 (1.225–2.876) 0.004* 1.856 (1.221–2.819)
Years since menopause (years) 7.0 ± 8.6 8.4 ± 8.7 0.821 0.997 (0.973–1.022)
Estrogen therapy, n (%) 104 (3.5) 11 (4.0) 0.771 0.912 (0.492–1.690)
Speed of sound in radius (m/s) 4195.9 ± 187.3 4162.4 ± 184.5 0.318 1.000 (0.999–1.000)
Speed of sound in tibia (m/s) 3859.1 ± 164.6 3832.1 ± 160.9 0.627 1.000 (0.999–1.001)
Data are presented as mean ± standard deviation or number of participants (%)
Crude univariate Cox regression model 1 did not control for any covariate
Cox regression model 2 controlled for age, weight, height, waist circumference, hip circumference, regular exercise, alcohol consumption, lifetime smoker,
history of fracture, family history of osteoporosis or fracture, degenerative arthritis, rheumatoid arthritis, hypertension, diabetes mellitus, years since
menopause, estrogen therapy, and quantitative ultrasound measurements at the radius and tibia
Cox regression model 3 with backward stepwise elimination involved a threshold of p = 0.1
Abbreviations: HR hazard ratio, CI confidence interval
*p < 0.05
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the exact mechanism by which snoring increases the fra-
gility fracture risk, treatment of snoring may become an
accepted approach to reduce the fragility fracture risk.
This study showed that snoring was significantly asso-
ciated with fragility fractures in women aged 40 years
and older. Although few if any previous studies have
specifically investigated the association between snoring
and fragility fractures, several previous studies have
analyzed the osteoporosis risk in OSA patients [6–9].
Snoring has been reported to be frequently associated
with OSA [10]. Moreover, Jennum et al. demonstrated
that snoring was associated with the respiratory distress
index, which was calculated as the number of apnea and
hypopnea episodes lasting longer than 10 s per hour
[13]. However, the authors mentioned that self-reported
snoring alone was not sensitive enough to identify in-
dividuals with sleep apnea [13]. The repetitive hypoxia
and subsequent reoxygenation that occur in OSA may
lead to oxidative stress, which may result in acidosis
because of insufficient vascular perfusion [7]. Further-
more, hypoxia may inhibit the proliferation of osteo-
blasts and promote proliferation of osteoclasts, resulting
in osteoporosis [7, 14]. A decrease in BMD caused by the
above-mentioned mechanisms may increase the fragility
fracture risk in the elderly.
Suzuki et al. investigated the association between sleep
disturbance and hip fracture risk, which may provide
more insights into the association between snoring and
an increase in the fracture risk [15]. In that study, the
authors followed participants for 6 months and reported
that there was a significant association between sleep
disturbance and hip fracture risk (odds ratio 2.60, 95%
confidence interval 1.31–5.17) [15]. Sleep disturbance
may increase the fracture risk in the elderly by decreasing
the alertness level during the daytime and thus increasing
the risk of falling [15]. However, further studies are needed
to investigate the exact association between snoring and
fragility fracture risk.
Zhang et al. demonstrated the associations between in-
somnia and falls using cross-sectional data (954 subjects)
in Boston, Massachusetts [16]. Adults with insomnia had
a 32% increased likelihood of falls after adjustment for
multiple covariates, but insomnia was not associated
with recurrent falls or fractures. The authors also assessed
snoring and falls; however, there was no significant dif-
ference. The study for insomnia and falls involved only
2 years of follow-up data. A longer follow-up duration
is required for fractures. Moreover, Upala et al. per-
formed a systematic review and meta-analysis of 9 arti-
cles to evaluate the association between OSA and the
risk of osteoporosis [17]. Their analysis did not find a
significant association between osteoporosis and OSA
or a difference in bone loss between the groups.
The present study has 4 limitations. First, we did not
investigate the OSA of subjects using polysomnography;
therefore, the definition of severe snoring in this study
was not experimentally verified. However, information
about snoring, which can easily be obtained with simple
questions, could be useful in pre-screening for fragility
fractures. Second, BMD was not measured with DXA.
However, qUS has been shown to be a fairly accurate
method for measuring BMD [18], and therefore, qUS is
being used in the clinical setting along with DXA. Third,
fracture history was not obtained from official medical
records maintained by physicians but was obtained from
survey results, which relied on the memory of the re-
spondents. Moreover, the memory of the respondents
about fractures was retrospective up to a 10-year lag,
and fracture time was asked by the year. Fourth, this co-
hort study was designed to investigate the genome-wide
association and associated risk factors of chronic disease
in urban and rural Koreans; therefore, it might be diffi-
cult to extend our findings to the general population.
Moreover, there were unmeasured confounders for
snoring and fractures, such as mental status, insomnia
disorders, dairy product consumption, and pregnancy
information.
Conclusions
This study showed that snoring is significantly associated
with fragility fracture risk in women aged 40 years and
older. Snoring may be associated with a decrease in
Log rank p < 0.001
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BMD and a decrease in the alertness level during the
daytime. These 2 health problems are in turn probably
associated with an increase in the fracture risk. Informa-
tion about snoring can easily be obtained with history
taking, and treatment options for snoring are available.
Thus, information on the frequency of snoring in
women may improve the accuracy of fragility fracture
risk prediction, which can help in deciding whether
intervention or treatment is necessary.
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